Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers
Investor's Business DailyRegeneron Pharmaceuticals topped third-quarter forecasts on Thursday, helped by a strong launch from its high dose of Eylea. REGN stock rose.
The post Regeneron Jumps On Third-Quarter Beat As High-Dose Eylea Delivers appeared first on Investor's B…